drugset / Trial / NCT01375387

Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males

NCT01375387

Phase 1 Completed 33 enrolled UCB Pharma
RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of lacosamide following single oral administration of lacosamide 100 mg, 200 mg and 400 mg in healthy male Chinese and Japanese subjects.

Timeline

Start
2011-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacosamide Other / unclassified 100 mg Oral
Subject Lacosamide Other / unclassified 200 mg Oral
Subject Lacosamide Other / unclassified 400 mg Oral

Indications

No indication recorded.